The 2025 National Alzheimer's Virtual Summit

The 2025 National Alzheimer's Summit is over, but don't worry – if you missed it, you can still watch the recorded sessions where we brought together leaders in science, policy, and advocacy for powerful conversations to drive real change.

UsAgainstAlzheimer’s Applauds Senate Appropriators for Robust Investments in Alzheimer’s Programs

These significant investments in research underscore the millions of Americans impacted by Alzheimer’s and other dementias.

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

UsAgainstAlzheimer's announced the launch of the BrainGuide Clinical Trial Connector, a free, confidential tool developed in partnership with Carebox. This new resource helps individuals, caregivers, and healthcare providers easily find and connect with clinical trials for Alzheimer’s disease and related dementias (ADRD).

UsAgainstAlzheimer’s Sounds the Alarm: Medicaid Cuts Will Worsen Alzheimer’s Crisis

As an organization dedicated to advocating for individuals and families impacted by Alzheimer’s disease and related dementias, UsAgainstAlzheimer’s is concerned by ongoing proposals that would likely cause millions of Americans to lose access to Medicaid.

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

The 2025 National Alzheimer's Virtual Summit

UsAgainstAlzheimer’s Applauds Robust Investments in Alzheimer’s Programs

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

UsAgainstAlzheimer’s Sounds the Alarm

Become a Member

VISION: UsAgainstAlzheimer's envisions a world without Alzheimer's where brainspan equals lifespan. 

MISSION: Catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments through advocacy, policy, convening, and high-leveraged programs, with a particular focus on health equity.   

 

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • Enhancing Brain Health and Reducing Dementia Risk - Key Recommendations from the NAPA Advisory Council

    The National Alzheimer's Project Act (NAPA) Advisory Council recently convened to discuss...

    Read more
  • August 01, 2024

    UsAgainstAlzheimer’s Applauds Senate Committee for $275 Million Increase in Alzheimer’s Research Funding

    Read more
  • July 31, 2024

    Nearly Half of Dementia Cases Could be Prevented or Delayed According to New Lancet Commission Report

    Read more
  • July 30, 2024

    U.S. Senate Passes Two Major Bills to Combat Alzheimer’s

    Read more
  • July 26, 2024

    European Regulators Put European Patients at Risk of Losing Groundbreaking Treatment

    Read more
  • July 02, 2024

    New Disease-Modifying Therapy Brings Good News for Early-Stage Alzheimer’s Patients

    Read more

Reports

  • Resources
    report

    2024 Annual Report

  • Resources
    2023 report

    2023 Annual Report

  • Resources

    2022 Annual Report